Sophie Ziegler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sophie Ziegler has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
E. Minar
University Hospital School of Medicine
2 shared publicationsAlfred Barth
Division of Occupational Medicine, Clinic for Internal medicine IV, University of Vienna of the Vienna General Hospital, Währinger Gürtel, Vienna, Austria
1 shared publicationAnsgar Weltermann
1 shared publicationCarina Zöch
Division of Occupational Medicine, Clinic for Internal medicine IV, University of Vienna of the Vienna General Hospital, Währinger Gürtel, Vienna, Austria
1 shared publicationE Eigenbauer
Institute of Medical Science, University Hospital School of Medicine, Vienna, Austria
1 shared publicationE Minar
Division of Angiology, Clinic for Internal Medicine II
1 shared publication
Latest Publications
- 1 January 2005
- Published by Elsevier in Thrombosis Research
- Vol. 115 (1-2) , 59-64
Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosis
- 1 January 2005
- Published by Elsevier in Thrombosis Research
- Vol. 115 (1-2) , 59-64
Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosis
- 1 November 2004
- Published by Elsevier in Microvascular Research
- Vol. 68 (3) , 203-208
Laser Doppler anemometry distinguishes primary Raynaud phenomenon from VWF syndrome
- 1 November 2004
- Published by Elsevier in Microvascular Research
- Vol. 68 (3) , 203-208
Laser Doppler anemometry distinguishes primary Raynaud phenomenon from VWF syndrome
- 1 November 2003
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 32 (6) , 343-347
Long‐term outcome of primary Raynaud's phenomenon and its conversion to connective tissue disease: a 12‐year retrospective patient analysis
To determine the frequency of development of connective tissue disease (CTD) in patients considered to have idiopathic Raynaud's phenomenon (RP) > 10 years.
- 1 November 2003
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 32 (6) , 343-347
Long‐term outcome of primary Raynaud's phenomenon and its conversion to connective tissue disease: a 12‐year retrospective patient analysis
To determine the frequency of development of connective tissue disease (CTD) in patients considered to have idiopathic Raynaud's phenomenon (RP) > 10 years.
- 10 October 2003
- Published by Springer Nature in Annals of Hematology
- Vol. 83 (2) , 92-94
Influence of systemic inflammation on efficiency of antiplatelet therapy in PAOD patients
Recently it was shown that inflammation adversely influences results obtained from the platelet function analyzer system, PFA-100, hypothesizing that inflammation could confound interpretation of platelet function results. We investigated the clinical relevance of these results in patients with peripheral arterial occlusive disease (PAOD), with and without signs of systemic inflammation. In 98 PAOD patients, all treated with acetyl-salicylic acid (ASA), we obtained PFA-100 values upon stimulation with epinephrine. C-reactive protein (CRP) values were investigated as indicator for systemic inflammation. Mean CRP levels were elevated in 23 patients (23%). There was no difference of mean PFA-100 results between patients with elevated CRP levels and those without. Our results indicate that the effect of ASA on platelet aggregation, as measured by the PFA-100, is not relevantly influenced in PAOD patients with elevated CRP.
- 10 October 2003
- Published by Springer Nature in Annals of Hematology
- Vol. 83 (2) , 92-94
Influence of systemic inflammation on efficiency of antiplatelet therapy in PAOD patients
Recently it was shown that inflammation adversely influences results obtained from the platelet function analyzer system, PFA-100, hypothesizing that inflammation could confound interpretation of platelet function results. We investigated the clinical relevance of these results in patients with peripheral arterial occlusive disease (PAOD), with and without signs of systemic inflammation. In 98 PAOD patients, all treated with acetyl-salicylic acid (ASA), we obtained PFA-100 values upon stimulation with epinephrine. C-reactive protein (CRP) values were investigated as indicator for systemic inflammation. Mean CRP levels were elevated in 23 patients (23%). There was no difference of mean PFA-100 results between patients with elevated CRP levels and those without. Our results indicate that the effect of ASA on platelet aggregation, as measured by the PFA-100, is not relevantly influenced in PAOD patients with elevated CRP.
- 1 September 2003
- Published by Springer Nature in Wiener klinische Wochenschrift
- Vol. 115 (15-16) , 575-579
High prevalence of chronic venous disease in hospital employees
Chronic venous disease (CVD), which comprises primary/idiopathic abnormalities of the venous system, and secondary sequels after deep venous thrombosis are major health issues in Western countries. The present study was conducted to prove the hypothesis that the development of CVD might be triggered by exogenous, occupational risk factors.
- 1 September 2003
- Published by Springer Nature in Wiener klinische Wochenschrift
- Vol. 115 (15-16) , 575-579
High prevalence of chronic venous disease in hospital employees
Chronic venous disease (CVD), which comprises primary/idiopathic abnormalities of the venous system, and secondary sequels after deep venous thrombosis are major health issues in Western countries. The present study was conducted to prove the hypothesis that the development of CVD might be triggered by exogenous, occupational risk factors.
- 1 January 2001
- Published by Elsevier in Thrombosis Research
- Vol. 101 (2) , 23-33
Post-thrombotic Syndrome After Primary Event of Deep Venous Thrombosis 10 to 20 Years Ago
- 1 January 2001
- Published by Elsevier in Thrombosis Research
- Vol. 101 (2) , 23-33
Post-thrombotic Syndrome After Primary Event of Deep Venous Thrombosis 10 to 20 Years Ago